when

Latest
Archive

by source

All Sources
Sources Page

department

Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access

therapeutic area

Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease

location & type

Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →

Sign In Subscribe

pharmadog

fetch the data · sniff the signal

Discover

Jobs
News

Hubs

Topics
Patent cliff
Publications

Tools

Compare
Search
Bookmarks

Trust

About
Sources
Contact

Legal

Privacy
Terms
Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

home
jobs
news
search

Small Molecule · news · pharmadog

← back to Small Molecule

News · Small Molecule

297 stories

May 29, 26Opinion: I’m a weight-loss doctor. Here’s why I worry about GLP-1 ‘microdoses’stat

May 28, 26Lilly obesity meds Foundayo and Zepbound to gain CVS coverageendpoints

May 28, 26GSK, Ionis unveil data for hepatitis B drug touted as ‘functional cure’biopharma dive

May 28, 26CVS obesity drug deal puts Lilly on equal footing with Novobiopharma dive

May 19, 26A migraine drugmaker heads to the public markets through reverse mergerbiopharma dive

May 18, 26Høeg fired in latest FDA shakeup; 20 people die after taking Amgen drugbiopharma dive

May 15, 26Opinion: Telehealth abortion with mifepristone continues, with backup plans still in placestat

May 14, 26STAT investigates the epidemic killing 178,000 Americans a yearstat

May 13, 26Evolving Oral SERD Research Seeks to Redefine Treatment Strategies in Hormone Receptor+ Breast Canceronclive

May 13, 26Dr Loghavi on the Significance of Updated WHO Diagnostic Criteria for AML in Clinical Practiceonclive

May 13, 26FDA Approves Decitabine/Cedazuridine Plus Venetoclax in Newly Diagnosed AMLonclive

May 13, 26FDA Approves Sonrotoclax for Relapsed/Refractory Mantle Cell Lymphomaonclive

May 13, 26Dr Dinardo on the FDA Approval of Decitabine/Cedazuridine Plus Venetoclax in AMLonclive

May 13, 26Tirabrutinib and CAR T-Cell Therapy Represent Potential Paradigm Shifts in R/R PCNSLonclive

May 13, 26Future Directions in Metastatic Castration-Resistant Prostate Canceronclive

May 13, 26Personalized Treatment Decision-Making in Metastatic Castration-Resistant Prostate Canceronclive

May 13, 26Future Radiopharmaceutical Strategies in Metastatic Castration-Resistant Prostate Canceronclive

May 13, 26Safety and Toxicity Management in Metastatic Castration-Resistant Prostate Canceronclive

May 13, 26Combination and Sequencing Strategies in Metastatic Castration-Resistant Prostate Canceronclive

May 13, 26Treatment Sequencing in Metastatic Castration-Resistant Prostate Canceronclive

May 13, 26Patient Selection for Radiopharmaceuticals in Metastatic Castration-Resistant Prostate Canceronclive

May 13, 26Alpha-Emitting Therapies in Metastatic Castration-Resistant Prostate Canceronclive

May 13, 26Combination Radiopharmaceutical Approaches in Metastatic Castration-Resistant Prostate Canceronclive

May 13, 26Radiopharmaceutical Strategies in Metastatic Castration-Resistant Prostate Canceronclive

May 13, 26Dr Bockorny on the Rationale for Targeting CCR8 in Solid Tumorsonclive

May 13, 26STAT+: Pharmalittle: We’re reading about FDA’s Makary resigning, a Lilly weight loss drug trial, and morestat

May 13, 26UCSF Receives Major Gift to Advance Research and Modernizationonclive

May 13, 26CLL-321 Trial Efficacy and Safety Results Analysisonclive

May 13, 26How Reimagined Research Endeavors Intersect With Dignified End-of-Life Care: With D. Ross Camidge, MD, PhD; and Charles D. Blanke, MD, FACP, FASCOonclive

May 13, 26BRUIN CLL-321 Trial Impact and Treatment Selectiononclive

← prevpage 7 of 10next →